New Test Could Help Breed Edema-Resistant Pigs
ARS News Service
Agricultural Research Service, USDA
Linda McGraw, (309) 681-6530, firstname.lastname@example.org
July 6, 1999
Hog farmers may be able to rear pigs with a natural ability to resist edema
disease caused by an intestinal E. coli bacteria. That's welcome news for
producers who lose money when young pigs get sick from a type of E. coli
U.S. Department of Agriculture researchers in Ames, Iowa, and the Pig
Improvement Company (PIC) of Franklin, Kentucky, cooperatively developed a
DNA-based test to identify pigs genetically resistant to the F18 E. coli
strain that causes edema. Rapid growth of F18 E. coli in the 3- to 14-
week-old pig's small intestine after weaning leads to edema disease,
characterized by a excessive build-up of body fluids. The F18 strain doesn't
cause disease in humans.
"This is a natural way of breeding healthier, more disease resistant pigs.
For producers, this strategy is a better alternative than increasing use of
antibiotics in animals. The cost of vaccines and antibiotics cuts into
producers profits," said Agricultural Research Service Administrator Floyd
Horn. ARS is USDA's chief scientific research agency.
ARS microbiologist Julia F. Ridpath at the National Animal Disease Center in
Ames, Iowa, and Brad Bosworth, who was an ARS veterinarian and is now a
group veterinary scientist with PIC, discovered resistance and
susceptibility to F18 is linked to a specific gene. A Swiss scientist, Peter
Voegeli, concurrently made the same discovery.
Ridpath and Bosworth have validated their test on more than 500 pigs.
"Pigs that are resistant to edema disease lack intestinal receptors. The
lack of receptors makes it impossible for this bacteria to stick or attach
to the intestinal wall," said Bosworth. The scientists also identified
another way to reduce the problems caused by the F18 E. coli bacteria: feed
weaned pigs more animal protein in place of soybean meal. This tactic
prevents the bacteria from taking hold in the susceptible pig.
The death rate among pigs with full-blown edema disease is about 25 percent.
ARS and the Biotechnology Research and Development Consortium (BRDC) in
Peoria, Illinois, hold a patent on the test. PIC has a worldwide exclusive
license for the commercial use of the technology except in Switzerland.
A story about the research appears in the July issue of ARS' Agricultural
Research magazine and on the web at:
Scientific contact: Julia Ridpath, ARS Enteric Diseases and Food Research,
National Animal Disease Center, P.O. Box 70, Ames, Iowa 50010; phone (515)
663-7372, fax (515) 663-7458, email@example.com.
This item is one of the news releases and story leads that ARS Information
distributes on weekdays to fax and e-mail subscribers. You can also get the
latest ARS news on the World Wide Web at
* Feedback and questions to ARS News Service via e-mail: firstname.lastname@example.org.
* ARS Information Staff, 5601 Sunnyside Ave., Room 1-2251, Beltsville MD
20705-5128, (301) 504-1617, fax 504-1648.
To Unsubscribe: Email email@example.com with the command
"unsubscribe sanet-mg". If you receive the digest format, use the command
To Subscribe to Digest: Email firstname.lastname@example.org with the command
All messages to sanet-mg are archived at: